Found: 31
Select item for more details and to access through your institution.
Self-reported cognitive functioning in postmenopausal breast cancer patients before and during endocrine treatment: findings from the neuropsychological TEAM side-study.
- Published in:
- Psycho-Oncology, 2012, v. 21, n. 5, p. 479, doi. 10.1002/pon.1928
- By:
- Publication type:
- Article
The Distress Thermometer assessed in women at risk of developing hereditary breast cancer.
- Published in:
- Psycho-Oncology, 2009, v. 18, n. 10, p. 1080, doi. 10.1002/pon.1451
- By:
- Publication type:
- Article
Passive coping and psychological distress in women adhering to regular breast cancer surveillance.
- Published in:
- Psycho-Oncology, 2007, v. 16, n. 9, p. 851, doi. 10.1002/pon.1135
- By:
- Publication type:
- Article
Breast Cancer Screening in High-Risk Women.
- Published in:
- Disease Markers, 1999, v. 15, n. 1-3, p. 34, doi. 10.1155/1999/160437
- By:
- Publication type:
- Article
A family history of breast cancer will not predict female early onset breast cancer in a population-based setting.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Ondansetron compared with high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting. A multicenter, randomized, double-blind, crossover study.
- Published in:
- 1990
- By:
- Publication type:
- journal article
Family system characteristics and psychological adjustment to cancer susceptibility genetic testing: a prospective study.
- Published in:
- Clinical Genetics, 2007, v. 71, n. 1, p. 35, doi. 10.1111/j.1399-0004.2007.00731.x
- By:
- Publication type:
- Article
Possible consequences of applying guidelines to healthy women with a family history of breast cancer.
- Published in:
- European Journal of Human Genetics, 2003, v. 11, n. 8, p. 633, doi. 10.1038/sj.ejhg.5201021
- By:
- Publication type:
- Article
Time dependence of biomarkers: non-proportional effects of immunohistochemical panels predicting relapse risk in early breast cancer.
- Published in:
- British Journal of Cancer, 2014, v. 111, n. 12, p. 2242, doi. 10.1038/bjc.2014.530
- By:
- Publication type:
- Article
Survival and contralateral breast cancer in CHEK2 1100delC breast cancer patients: impact of adjuvant chemotherapy.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Survival and contralateral breast cancer in CHEK2 1100delC breast cancer patients: impact of adjuvant chemotherapy.
- Published in:
- British Journal of Cancer, 2014, v. 111, n. 5, p. 1004, doi. 10.1038/bjc.2014.306
- By:
- Publication type:
- Article
Do type 1 receptor tyrosine kinases inform treatment choice? A prospectively planned analysis of the TEAM trial.
- Published in:
- British Journal of Cancer, 2013, v. 109, n. 9, p. 2453, doi. 10.1038/bjc.2013.609
- By:
- Publication type:
- Article
The impact of CYP2D6-predicted phenotype on tamoxifen treatment outcome in patients with metastatic breast cancer.
- Published in:
- 2010
- By:
- Publication type:
- journal article
The prognostic and predictive value of Tregs and tumor immune subtypes in postmenopausal, hormone receptor-positive breast cancer patients treated with adjuvant endocrine therapy: a Dutch TEAM study analysis.
- Published in:
- Breast Cancer Research & Treatment, 2015, v. 149, n. 3, p. 587, doi. 10.1007/s10549-015-3269-7
- By:
- Publication type:
- Article
CYP2D6 genotype in relation to tamoxifen efficacy in a Dutch cohort of the tamoxifen exemestane adjuvant multinational (TEAM) trial.
- Published in:
- Breast Cancer Research & Treatment, 2013, v. 140, n. 2, p. 363, doi. 10.1007/s10549-013-2619-6
- By:
- Publication type:
- Article
Quality of life in relation to tamoxifen or exemestane treatment in postmenopausal breast cancer patients: a Tamoxifen Exemestane Adjuvant Multinational (TEAM) Trial side study.
- Published in:
- Breast Cancer Research & Treatment, 2012, v. 134, n. 1, p. 267, doi. 10.1007/s10549-012-2028-2
- By:
- Publication type:
- Article
Tumor characteristics and detection method in the MRISC screening program for the early detection of hereditary breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2007, v. 102, n. 3, p. 357, doi. 10.1007/s10549-006-9341-6
- By:
- Publication type:
- Article
Randomized Phase II Study Comparing Efficacy and Safety of Combination-Therapy Trastuzumab and Docetaxel vs. Sequential Therapy of Trastuzumab Followed by Docetaxel Alone at Progression As First-Line Chemotherapy in Patients with HER2(+) Metastatic Breast Cancer: HERTAX Trial.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Microsatellite instability in a pleomorphic rhabdomyosarcoma in a patient with hereditary non-polyposis colorectal cancer.
- Published in:
- Histopathology, 2003, v. 43, n. 3, p. 297, doi. 10.1046/j.1365-2559.2003.01681.x
- By:
- Publication type:
- Article
Combined treatment with buserelin and tamoxifen in premenopausal metastatic breast cancer: a randomized study.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Repeated Nipple Fluid Aspiration: Compliance and Feasibility Results from a Prospective Multicenter Study.
- Published in:
- PLoS ONE, 2015, v. 10, n. 5, p. 1, doi. 10.1371/journal.pone.0127895
- By:
- Publication type:
- Article
Impact of screening for breast cancer in high-risk women on health-related quality of life.
- Published in:
- British Journal of Cancer, 2004, v. 91, n. 1, p. 69, doi. 10.1038/sj.bjc.6601912
- By:
- Publication type:
- Article
Contralateral breast cancer risk is influenced by the age at onset in BRCA1-associated breast cancer.
- Published in:
- British Journal of Cancer, 2000, v. 83, n. 3, p. 384, doi. 10.1054/bjoc.2000.1239
- By:
- Publication type:
- Article
Timing of risk reducing mastectomy in breast cancer patients carrying a BRCA1/2 mutation: retrospective data from the Dutch HEBON study.
- Published in:
- Familial Cancer, 2015, v. 14, n. 3, p. 355, doi. 10.1007/s10689-015-9788-x
- By:
- Publication type:
- Article
Breast Cancer Risk After Salpingo-Oophorectomy in Healthy BRCA1/2 Mutation Carriers: Revisiting the Evidence for Risk Reduction.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2015, v. 107, n. 5, p. 1, doi. 10.1093/jnci/djv033
- By:
- Publication type:
- Article
Breast Cancer Risk After Salpingo-Oophorectomy in Healthy BRCA1/2 Mutation Carriers: Revisiting the Evidence for Risk Reduction.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
Novel Endocrine Therapies in Breast Cancer.
- Published in:
- Acta Oncologica, 1996, v. 35, n. S5, p. 30, doi. 10.3109/02841869609083965
- By:
- Publication type:
- Article
Variations in locoregional therapy in postmenopausal patients with early breast cancer treated in different countries.
- Published in:
- British Journal of Surgery, 2010, v. 97, n. 5, p. 671, doi. 10.1002/bjs.6962
- By:
- Publication type:
- Article
Contralateral recurrence and prognostic factors in familial non-BRCA1/2-associated breast cancer.
- Published in:
- British Journal of Surgery, 2006, v. 93, n. 8, p. 961, doi. 10.1002/bjs.5344
- By:
- Publication type:
- Article
Outcomes of First-Line Chemotherapy in Patients with Advanced or Metastatic Leiomyosarcoma of Uterine and Non-Uterine Origin.
- Published in:
- Sarcoma, 2009, v. 2009, p. 1, doi. 10.1155/2009/348910
- By:
- Publication type:
- Article
Effects of CYP Induction by Rifampicin on Tamoxifen Exposure.
- Published in:
- Clinical Pharmacology & Therapeutics, 2012, v. 92, n. 1, p. 62, doi. 10.1038/clpt.2011.372
- By:
- Publication type:
- Article